OneMedNet reports greater than five-fold expansion of iRWD network and platform; posts new investor presentation

OneMedNet’s (Nasdaq:ONMD) stock rallied over 208% on more than 420 times average trading volumes today after reporting a greater than five-fold expansion of its proprietary iRWD network and platform through a series of new network partnership agreements, including one recently signed with an undisclosed nationwide medical records custodian.

Employing its robust iRWD platform, OneMedNet provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results and, uniquely, medical imaging. The company securely de-identifies, searches, and curates the clinical data, delivering a wealth of internal and third-party research opportunities to its drug, medical device, and imaging/diagnostic AI development customers.

OneMedNet is now offering its growing base of customers seamless access to an expanded set of RWD across its robust network comprised of:

  • 1,402 healthcare system and provider partner sites;
  • 31.0 million patients; and
  • 121.4 million clinical exams.

The company noted the year-to-date increases in partner sites, patients and clinical exams represent growth of 472%, 170% and 122%, respectively, since the end of 2023.

“As demonstrated by this significant expansion of our network, we continue to successfully execute against the key pillars of our growth strategy,” said Aaron Green, OneMedNet’s President and CEO. “Our vision is to harness the full potential of RWD to drive innovation in healthcare. By providing our customers with comprehensive access to valuable, regulatory-grade clinical data across our growing network, we are not just furnishing more numbers — we are delivering the de-identified and hard-to-curate information needed to help foster a new era of medical excellence.”

Separately, OneMedNet filed an 8-K with the SEC, disclosing its new investor presentation.